As NF1-associated MPNST develops from NF1-nullizygous plexiform neurofibromas (PN), they acquire mutations in other driver genes such as TP53 and cyclin-dependent kinase inhibitor 2A (CDKN2A). This evidence concerns the gene CDKN2A and malignant peripheral nerve sheath tumor.